Inventory / revenue moved 2495 bp higher
Inventory / revenue changed +2495 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +2495 basis points from the comparable as-filed period.
Receivables / revenue changed +2191 basis points from the comparable as-filed period.
Cost of revenue changed +22.6% from the comparable as-filed period.
Operating cash-flow margin changed -1118 basis points from the comparable as-filed period.
Current ratio changed -24.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +17.7% from the comparable as-filed period.
Cash & equivalents changed -7.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed -96 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed +125 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +9.9% from the comparable as-filed period.
Stock-based compensation changed -14.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -59 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.